Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12688/aasopenres.13059.1 http://scihub22266oqcxt.onion/10.12688/aasopenres.13059.1 32537561!7255909!32537561     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       AAS+Open+Res 2020 ; 3 (ä): 8 Nephropedia Template TP {{tp|p=32537561|t=2020. Current and emerging diagnostic tests available for the novel COVID-19 global pandemic |pdf=|usr=}}{{32537561}} gab.com Text Current and emerging diagnostic tests available for the novel COVID-19 global pandemic JO: AAS Open Res http://www.kidney.de/pget.php?&tw=1&pmid=32537561 #FOAvip On March 11, 2020 the World Health Organization (WHO) upgraded the status of the coronavirus disease 2019 (COVID-19) outbreak from epidemic to a global pandemic. This infection is caused by a novel coronavirus, SARS-CoV-2. Several rapid diagnostic tests have been developed at an astonishing pace; however, COVID-19 requires more highly specific rapid point-of-care diagnostic tests. This review describes the currently available testing approaches, as well as the available test assays including the Xpert(R) Xpress SARS-CoV-2 test (takes (~)45 min) and Abbott ID COVID-19 test (5 min) as easy to use point-of-care tests for diagnosis of novel COVID-19 that have so far received the US Food and Drug Administration emergency use authorizations clearance. This review is correct as of the date published and will be updated as more diagnostic tests come to light. Twit Text FOAVip Current and emerging diagnostic tests available for the novel COVID-19 global pandemic ????AAS Open Res http://www.kidney.de/pget.php?&tw=1&pmid=32537561 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32537561 #FOAvip English Wikipedia <ref>{{Cite pmid|32537561}}</ref> Current and emerging diagnostic tests available for the novel COVID-19 global pandemic #MMPMID32537561 Mboowa G AAS Open Res 2020[]; 3 (ä): 8 PMID32537561show ga On March 11, 2020 the World Health Organization (WHO) upgraded the status of the coronavirus disease 2019 (COVID-19) outbreak from epidemic to a global pandemic. This infection is caused by a novel coronavirus, SARS-CoV-2. Several rapid diagnostic tests have been developed at an astonishing pace; however, COVID-19 requires more highly specific rapid point-of-care diagnostic tests. This review describes the currently available testing approaches, as well as the available test assays including the Xpert(R) Xpress SARS-CoV-2 test (takes (~)45 min) and Abbott ID COVID-19 test (5 min) as easy to use point-of-care tests for diagnosis of novel COVID-19 that have so far received the US Food and Drug Administration emergency use authorizations clearance. This review is correct as of the date published and will be updated as more diagnostic tests come to light. äCurrent and emerging diagnostic tests available for the novel COVID-19(epmc).pdf DeepDyve Pubget Overpricing